Martens, Kylee L <br/><br/>
Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia.  [electronic resource] 

 -  Leukemia research  02 2020 
 - 106298 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2020.106298  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Allopurinol--administration & dosage<br/>Female<br/>Humans<br/>Hyperuricemia--drug therapy<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasms--complications<br/>Odds Ratio<br/>Prognosis<br/>Propensity Score<br/>Renal Insufficiency--drug therapy<br/>Retrospective Studies<br/>Treatment Outcome<br/>Tumor Lysis Syndrome--etiology<br/>Urate Oxidase--therapeutic use<br/>Uric Acid--urine